Internal Medicine, Pulmonary Disease · Lake Havasu City, AZ
NPI
1659368751
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1830 Mesquite Ave, Suite C
Lake Havasu City, AZ, 86403
Phone (928) 855-6966
Groups this clinician bills Medicare through
Medicare paid, 2024
$297K
4,229 services
Medicare patients, 2024
1,048
Average age 76
Drug cost, 2024
$2.9M
5,024 prescriptions
Company payments, 2025
$2,238
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Heidi A Berdin was code 99214 (office e&m - established), 1,399 times for 771 patients. In total Heidi A Berdin billed 4,229 services in 22 codes, and Medicare paid $297K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,399 | 771 | $89.90 | $126K |
| 99215 Office E&M - Established | Office | 714 | 449 | $131.23 | $94K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 573 | 27 | $0.09 | $50.74 |
| 94060 Pulmonary Function Testing | Office | 241 | 236 | $25.87 | $6,234 |
| 94726 Pulmonary Function Testing | Office | 240 | 235 | $38.15 | $9,156 |
| 94729 Pulmonary Function Testing | Office | 240 | 236 | $39.88 | $9,572 |
| 99205 Office E&M - New | Office | 183 | 183 | $151.09 | $28K |
| 99213 Office E&M - Established | Office | 172 | 148 | $63.55 | $11K |
| J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | Office | 140 | 139 | $0.03 | $3.71 |
| 94664 E&M - Miscellaneous | Office | 70 | 58 | $12.58 | $880 |
| 94640 Treatment - Miscellaneous | Office | 59 | 59 | $6.12 | $361 |
| 96372 Injection Administration | Office | 57 | 27 | $10.88 | $620 |
| 99204 Office E&M - New | Office | 47 | 47 | $116.81 | $5,490 |
| 94618 Pulmonary Function Testing | Office | 35 | 29 | $26.33 | $922 |
By year: 2022 $421K for 5,334 services; 2023 $377K for 5,106 services; 2024 $297K for 4,229 services.
Medicare prescription drug claims, 2024
In 2024, the drug Heidi A Berdin prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 774 prescriptions and refills. In total Heidi A Berdin wrote 5,024 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 774 | 1,022 | 265 | $27K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 665 | 1,036 | 164 | $630K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 663 | 1,024 | 156 | $634K |
| Azithromycin Generic | 478 | 643 | 165 | $4,304 |
| Prednisone Generic | 406 | 467 | 152 | $1,528 |
| Montelukast Sodium Generic | 144 | 334 | 36 | $1,528 |
| Fluticasone Propionate Generic | 117 | 210 | 56 | $1,991 |
| Symbicort Budesonide/Formoterol Fumarate | 117 | 183 | 28 | $42K |
| Spiriva Respimat Tiotropium Bromide | 116 | 171 | 31 | $85K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 97 | 163 | 32 | $17K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 93 | 123 | 23 | $53K |
| Losartan Potassium Generic | 85 | 168 | 28 | $433 |
| Breo Ellipta Fluticasone/Vilanterol | 84 | 90 | 15 | $35K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 77 | 147 | 21 | $67K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 72 | 72 | 63 | $539 |
Brand drugs: 2,866 claims; generic drugs: 2,158 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Heidi A Berdin $2,238 ($2,238 in general payments such as food, travel and fees) from 15 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $600.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $600 |
| Merck Sharp & Dohme LLC MRK | 8 | $331 |
| GlaxoSmithKline, LLC. GSK | 10 | $240 |
| Insmed, Inc. INSM | 10 | $211 |
| Verona Pharma, Inc. VRNA | 10 | $166 |
| United Therapeutics Corporation UTHR | 5 | $129 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $113 |
| Baxter Healthcare BAX | 4 | $101 |
| Actelion Pharmaceuticals US, Inc. JNJ | 3 | $95.38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $76.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.